ATAI Life Sciences N.V. Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ATAI Life Sciences N.V. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q3 2024.
  • ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$178K, a 175% decline year-over-year.
  • ATAI Life Sciences N.V. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $265K, a 96% decline year-over-year.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2023 was $1.02M, a 83.7% decline from 2022.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2022 was $6.23M, a 56.2% increase from 2021.
  • ATAI Life Sciences N.V. annual Income Tax Expense (Benefit) for 2021 was $3.99M, a 1208% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $265K -$178K -$416K -175% Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-14
Q2 2024 $681K $19K -$166K -89.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $847K -$4K -$169K -102% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.02M $428K -$5.57M -92.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $6.59M $238K +$103K +76.3% Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-11-14
Q2 2023 $6.49M $185K +$134K +263% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $6.35M $165K +$124K +302% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $6.23M $6M +$2.45M +68.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.78M $135K -$233K -63.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $4.02M $51K -$7K -12.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.02M $41K +$35K +583% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.99M $3.56M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $368K +$364K +9100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $58K +$58K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $6K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $4K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.